BML Investment Partners L.P. 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 10:50 am Sale | 2023-12-31 | 13G | Quince Therapeutics, Inc. QNCX | BML Investment Partners L.P. | 0 0.000% | -1,841,301 (Position Closed) | Filing |
| 2023-07-17 11:07 am Purchase | 2023-07-06 | 13G | Quince Therapeutics, Inc. QNCX | BML Investment Partners L.P. | 1,841,301 5.070% | 1,841,301 (New Position) | Filing |